このページは http://www.slideshare.net/DavidAndrews11/london-talk-tetrahedron の内容を掲載しています。
We describe what we have learned from four years of collaborating across the industry/not-for-pro...
We describe what we have learned from four years of collaborating across the industry/not-for-profit boundary. Over this time we pursued multiple projects and some of the lessons learned are described here.
Many large pharma companies have reduced their research activity at the very early, hit- and lead- seeking phase of research. To compensate, organisations are becoming more porous and working more collaboratively in risk-sharing arrangements. Both parties need to give up some control, but gain a great deal in return